💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

Exclusive: Bayer to win EU approval for $62.5 billion Monsanto deal

Published 02/28/2018, 08:59 AM
© Reuters. FILE PHOTO: The logo of Bayer AG
BASFN
-
BAYGN
-
MON
-

By Foo Yun Chee

BRUSSELS (Reuters) - German drug and crop chemicals maker Bayer (DE:BAYGn) is set to win conditional European Union antitrust approval for its $62.5 billion bid for world No. 1 seed company Monsanto (N:MON), two people familiar with the matter said on Wednesday.

The takeover, one of a trio of major deals in the agribusiness sector in recent years, would create a company with a share of more than a quarter of the world's seed and pesticides market.

Shifting weather patterns, competition in grain exports and a souring global farm economy have spurred consolidation among the major players, triggering protests from environmental and farming groups worried about their market power.

Bayer has already pledged to sell certain seed and herbicide assets for 5.9 billion euros ($7.2 billion) to BASF (DE:BASFn) to address EU regulatory concerns.

The company will also give BASF a license to its digital farming data, and it appears BASF will have exclusive access as Bayer has not offered a legal obligation to license to other rivals, a person with knowledge of the matter has told Reuters.

Earlier on Wednesday, Bayer said additional antitrust concessions would include the sale of its vegetable seeds business, confirming a Reuters report.

The European Commission, which is expected to issue a decision on the deal ahead of its April 5 deadline, declined to comment.

Bayer also declined to comment on the sources' comments, saying it continued a constructive dialogue with the EU competition watchdog. It added the regulatory process in Europe was further advanced than in the United States where the deal also requires clearance.

French seeds producer Vilmorin said it would consider taking over some vegetable seed activities put up for sale by Bayer.

"It will depend on the breakdown that will be made. If there are clever and targeted things to do, why not, but if it's all-encompassing then clearly we don't have the profile for it to be accepted by the authorities," Vilmorin Chief Executive Daniel Jacquemond told reporters after unveiling first-half results.

The Bayer-Monsanto tie-up has sparked criticism from environmentalists and some farming groups concerned about its market power and first mover advantage in digital farming data.

Some who met on Tuesday with European Competition Commissioner Margrethe Vestager, who has received more than 50,000 petition emails and more than 5,000 letters opposed to the deal, were not reassured.

"Approving this merger would create the world's biggest agribusiness company, potentially crushing competitors and establishing an unprecedented monopoly on lucrative farming data," said Adrian Bebb at environmental lobbying group Friends of the Earth Europe.

"Public opinion is against the merger, and farmers and consumers would have every right to be outraged by the Commission giving it the green light."

© Reuters. FILE PHOTO: The logo of Bayer AG

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.